SCHEMBL5717229

SCHEMBL5717229

CC[C@@]1(C(=O)O)CCCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
TRPA1 O75762 3/20 0.41
GAA P10253 1/20 0.40
TRPV4 Q9HBA0 3/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39
MMP8 P22894 1/20 0.39
MMP13 P45452 1/20 0.39
MMP14 P50281 1/20 0.39
BRD4 O60885 3/20 0.39
BRD2 P25440 2/20 0.39
EPHX2 P34913 3/20 0.39
KDM2B Q8NHM5 1/20 0.39
SLC6A4 P31645 1/20 0.38
BRD3 Q15059 1/20 0.38
BRDT Q58F21 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717206 1.00 ALDH1A1 (0.43) ALDH1A1TRPA1GAATRPV4MMP2
SCHEMBL5717180 0.85 ITGB1 (0.38) ALDH1A1TRPA1GAA
SCHEMBL5717014 0.84 ITGB1 (0.36) ALDH1A1TRPA1
SCHEMBL5717084 0.83 ITGB1 (0.39) ALDH1A1TRPA1
SCHEMBL5717025 0.83 EPHX2 (0.44) ALDH1A1TRPA1TRPV4EPHX2HCRTR1
SCHEMBL5717017 0.83 HCRTR1 (0.44) ALDH1A1TRPV4HCRTR1HCRTR2
SCHEMBL5717033 0.82 ALDH1A1 (0.49) ALDH1A1TRPA1GAATRPV4EPHX2
SCHEMBL5717098 0.81 TDP1 (0.39) ALDH1A1HCRTR1HCRTR2
SCHEMBL5717006 0.80 ALDH1A1 (0.44) ALDH1A1TRPA1GAATRPV4BRD4
SCHEMBL5717214 0.79 ALDH1A1 (0.43) ALDH1A1TRPA1GAATRPV4MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664010-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS Vernalis (R&D) Limited (GB) 2006-06-07 EP disclosed
WO-2005068448-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2005-07-28 WO disclosed